KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Beginning Cash Balance: 2017-2025

Historic Beginning Cash Balance for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $539.0 million.

  • Elanco Animal Health's Beginning Cash Balance rose 29.57% to $539.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $490.0 million, marking a year-over-year increase of 32.79%. This contributed to the annual value of $352.0 million for FY2024, which is 2.03% up from last year.
  • As of Q3 2025, Elanco Animal Health's Beginning Cash Balance stood at $539.0 million, which was up 10.68% from $487.0 million recorded in Q2 2025.
  • Elanco Animal Health's Beginning Cash Balance's 5-year high stood at $638.0 million during Q1 2022, with a 5-year trough of $318.0 million in Q2 2023.
  • Its 3-year average for Beginning Cash Balance is $408.7 million, with a median of $369.0 million in 2023.
  • Data for Elanco Animal Health's Beginning Cash Balance shows a peak YoY increase of 51.50% (in 2021) and a maximum YoY decrease of 58.30% (in 2021) over the last 5 years.
  • Over the past 5 years, Elanco Animal Health's Beginning Cash Balance (Quarterly) stood at $453.0 million in 2021, then grew by 1.55% to $460.0 million in 2022, then decreased by 19.78% to $369.0 million in 2023, then surged by 32.79% to $490.0 million in 2024, then climbed by 29.57% to $539.0 million in 2025.
  • Its Beginning Cash Balance was $539.0 million in Q3 2025, compared to $487.0 million in Q2 2025 and $468.0 million in Q1 2025.